2017
DOI: 10.1073/pnas.1706076114
|View full text |Cite
|
Sign up to set email alerts
|

Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF

Abstract: Developing therapeutic approaches are necessary for treating hormone-refractory prostate cancer. Activation of androgen receptor (AR) and its variants' expression along with the downstream signals are mostly important for disease progression. However, the mechanism for marked increases of AR signals and its expression is still unclear. Here, we revealed that various spliceosome genes are aberrantly induced by RNA-binding protein PSF, leading to enhancement of the splicing activities for AR expression. Our high… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
118
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 90 publications
(123 citation statements)
references
References 39 publications
5
118
0
Order By: Relevance
“…By using CLIP‐seq data, we found that Sfpq/Psf interacts with the App transcript at intronic regions, mainly intron 1 (Figure a). In line with this result, using RIP‐seq analysis of PSF in human prostate cancer cells (Takayama et al, ), we also found that APP transcripts interact with PSF at the RNA level. The ChIP‐seq data of RNA polII in mouse neuronal Neuro2a cells treated with siControl or siSfpq/Psf showed no obvious change in the distribution of polII binding after Sfpq/Psf silencing (Figure b), suggesting that App may not be regulated at transcription level.…”
Section: Resultssupporting
confidence: 86%
See 2 more Smart Citations
“…By using CLIP‐seq data, we found that Sfpq/Psf interacts with the App transcript at intronic regions, mainly intron 1 (Figure a). In line with this result, using RIP‐seq analysis of PSF in human prostate cancer cells (Takayama et al, ), we also found that APP transcripts interact with PSF at the RNA level. The ChIP‐seq data of RNA polII in mouse neuronal Neuro2a cells treated with siControl or siSfpq/Psf showed no obvious change in the distribution of polII binding after Sfpq/Psf silencing (Figure b), suggesting that App may not be regulated at transcription level.…”
Section: Resultssupporting
confidence: 86%
“…ChIP and quantitative PCR (qPCR) were conducted as previously described (Takayama et al, , ). The fold enrichment relative to input was measured by performing qPCR using the KAPA SYBR Green PCR Master Mix (Sigma Genosys) and Applied Biosystems StepOne.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The generated cDNA was subjected to real‐time PCR using an Applied Biosystems Step one plus real‐time PCR system based on SYBR Greenfluorescence (NIPPON Genetics, Tokyo, Japan). mRNA expression levels were normalized by GAPDH, and qRT‐PCR was undertaken as previously described . The following PCR primer sequences were used for qRT‐PCR: GAPDH forward, 5′‐ GGTGGTCTCCTCTGACTTCAACA; GAPDH reverse, 5′‐ GTGGTCGTTGAGGGCAATG; TRIM36 forward, 5′‐ AGTTCTGGAAGAGAGGAAATC‐3′; TRIM36 reverse, 5′‐ TCCATTTGAGTCTGAAATTG‐3′; BAX forward, 5′‐GTCGCCCTTTTCTACTTTGC‐3′; BAX reverse, 5′‐CTCAGCCCATCTTCTTCCAG‐3′; TNFSF10 forward, 5′‐AGACCTGCGTGCTGATGATCGTG‐3′; and TNFSF10 reverse, 5′‐CAAGCAATGCCACTTTTGCA‐3′.…”
Section: Methodsmentioning
confidence: 99%
“…Recently, dysregulation of CHERP expression has been implicated in several cancers. For example, elevated expression of CHERP was observed in neuroblastoma and castration‐resistant prostate cancer . These studies provided evidence that CHERP plays an important role in promoting tumor growth.…”
Section: Introductionmentioning
confidence: 99%